Diagnosis of tuberous sclerosis complex focusing on prenatal period
Authors:
H. Filipová; M. Procházka; R. Vrtěl
Authors‘ workplace:
Ústav lékařské genetiky FN a LF UP Olomouc
přednosta doc. MUDr. M. Procházka, Ph. D.
Published in:
Ceska Gynekol 2016; 81(2): 147-154
Overview
Tuberous sclerosis is a disease with an autosomal dominant pattern of inheritance which is characterized by the development of benign tumours in many tissues and organs. Clinical signs are extremely variable, causing mutations in the gene TSC1 or TSC2. Complex formed by the products of the TSC genes regulates cell growth and proliferation by inhibition of mTORC1 signalling. Early diagnosis of TSC is very important to plan appropriate perinatal care. Using ultrasound and eventually MRI it is possible in the prenatal period to capture the following major features of tuberous sclerosis: cardiac rhabdomyoma, subependymal nodules, cortical tubers and renal angiomyolipomas. In connection with the syndrome of contiguous genes TSC2 / PKD1 can also be detect foetal renal cysts. Often these TSC-associated lesions represent an incidental finding during a routine ultrasound. In the period from the 20th week of pregnancy it is most often found cardiac rhabdomyoma/s as the first marker suggestive of tuberous sclerosis. In the case, where one of the parents is a carrier of already identified mutation in the TSC gene, it is possible to carry out targeted genetic testing of a sample of DNA isolated from cells of chorionic villi, amniocytes or tissue from aborted foetuses. Significantly more time consuming is to perform molecular analysis of the TSC genes in foetuses with suspected tuberous sclerosis without the occurrence of illness in the family. After finding a causal mutation and its confirmation, it is possible to offer genetic testing for other persons at risk, prenatal (eventually preimplantation) diagnosis for future pregnancies. It is also necessary to consider the possibility of gonadal mosaicism.
Design:
Review of the literature.
Keywords:
tuberous sclerosis complex, TSC1, TSC2, foetal rhabdomyoma, sequencing, mosaicism
Sources
1. Bisceglia, M., D'Alessandro, V., Simeone, A., et al. Selected case from the Arkadi M. Rywlin International Pathology Slide Seminar: Sporadic lymphangioleiomyomatosis. Adv Anat Pathol, 2010, 17(6), p. 445–452.
2. Colosi, E., Russo, C., Macaluso, G., et al. Sonographic diagnosis of fetal cardiac rhabdomyomas and cerebral tubers: a case report of prenatal tuberous sclerosis. J Prenat Med, 2013, 7(4), p. 51–55.
3. Dabora, SL., Jozwiak, S., Franz, DN., et al. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet, 2001, 68, p. 64–80.
4. European Chromosome 16 Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell, 1993, 31, 75(7), p. 1305–1315.
5. Franz, D., Belousova, E., Sparagana, S., et al. Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial. Lancet, 2012, 381, p. 125–132.
6. Gedikbasi, A., Oztarhan, K., Ulker, V., et al. Pre-natal sonographic diagnosis of tuberous sclerosis complex. J Clin Ultrasound, 2011, 39(7), p. 427–430.
7. Gómez, MR., Sampson, JR., Whittemore, VH. Tuberous sclerosis complex, Developmental perspectives in psychiatry. Oxford University Press, New York 1999, 3rd ed., p. 313–316, 195.
8. Goyer, I., Dahdah, N., Major, P. Use of mTOR inhibitor everolimus in three neonates for treatment of tumors associated with tuberous sclerosis complex. Pediatr Neurol, 2015, 52(4), p. 450–453.
9. Gusman, M., Servaes, S., Feygin, T., et al. Multimodal imaging in the prenatal diagnosis of tuberous sclerosis complex. Case Rep Pediatr, 2012, 2012, p. 925646.
10. Hinton, RB., Prakash, A., Romp, RL., Krueger, DA., Knilans, TK., International Tuberous Sclerosis Consensus Group. Cardiovascular manifestations of tuberous sclerosis complex and summary of the revised diagnostic criteria and surveillance and management recommendations from the International Tuberous Sclerosis Consensus Group. Am Heart Assoc. 2014, 25; 3(6): e001493 doi 10.1161/JAHA.114.001493
11. Hoogeveen-Westerveld, M., Ekong, R., Povey, S., et al. Functional assessment of TSC1 missense variants identified in individuals with tuberous sclerosis complex. Hum Mutat, 2012, 33, p. 476–479.
12. Hoogeveen-Westerveld, M., Ekong, R., Povey, S., et al. Functional assessment of TSC2 variants identified in individuals with tuberous sclerosis complex. Hum Mutat, 2013, 34, p. 167–175.
13. Ichikawa, T., Wakisaka, A., Daido, S., et al. A case of solitary subependymal giant cell astrocytoma: two somatic hits of TSC2 in the tumor, without evidence of somatic mosaicism. J Mol Diagn, 2005, 7(4), p. 544–549.
14. Kingswood, JC., Jozwiak, S., Belousova, ED., et al. The effect of everolimus on renal angiomyolipoma in patients with tuberous sclerosis complex being treated for subependymal giant cell astrocytoma: subgroup results from the randomized, placebo-controlled, Phase 3 trial EXIST-1. Nephrol Dial Transplant, 2014, 29(6), p. 1203–1210.
15. Kozlowski, P., Roberts, P., Dabora, S., et al. Identification of 54 large deletions/duplications in TSC1 and TSC2 using MLPA, and genotype-phenotype correlations. Hum Genet, 2007, 121(3–4), p. 389–400.
16. Mohamed, I., Ethier, G., Goyer, I., et al. Oral everolimus treatment in a preterm infant with multifocal inoperable cardiac rhabdomyoma associated with tuberous sclerosis complex and a structural heart defect. BMJ Case Rep, 2014, 26. doi: 10.1136/bcr-2014-205138.
17. Northrup, H., Krueger, D. The International Tuberous Sclerosis Complex Consensus Group. Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol, 2013, 49, p. 243–254.
18. Northrup, H., Krueger, D. Tuberous Sclerosis Complex Surveillance and Management: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol, 2013, 49(4), p. 255–265.
19. Prabowo, AS., Anink, JJ., Lammens, M., et al. Fetal brain lesions in tuberous sclerosis complex: TORC1 activation and inflammation. Brain Pathol, 2013, 23(1), p. 45–59.
20. Roach, E., Gomez, M., Northrup, H. Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J Child Neurol, 1998, 13, p. 624–628.
21. Rose, VM., Au, KS., Pollom, G., et al. Germ-line mosaicism in tuberous sclerosis: how common? Am J Hum Genet, 1999, 64(4), p. 986–992.
22. Roux, PP., Ballif, BA., Anjum, R., et al. Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribo-somal S6 kinase. Proc Natl Acad Sci USA, 2004, 101(37), p. 13489–13494.
23. Sancak, O., Nellist, M., Goedbloed, M., et al. Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype-phenotype correlations and comparison of diagnostic DNA techniques in Tuberous Sclerosis Complex. Eur J Hum Genet, 2005, 13(6), p. 731–741.
24. Tyburczy, ME., Dies, KA., Glass, J., et al. Mosaic and Intronic Mutations in TSC1/TSC2 Explain the Majority of TSC Patients with No Mutation Identified by Conventional Testing. PLoS Genet, 2015, 11(11), p. e1005637.
25. van Slegtenhorst, M., deHoogt, R., Hermans, C., et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science, 1997, 277, p. 805–808.
26. Verhoef, S., Bakker, L., Tempelaars, AM., et al. High rate of mosaicism in tuberous sclerosis complex. Am J Hum Genet, 1999, 64(6), p. 1632–1637.
27. Vrtěl, R., Filipová, H., Vodička, R., et al. Tuberózní skleróza. Klin Onkol, 2009, 22 (Suppl. 1), p. 50-53.
28. Vrtel, R., Verhoef, S., Bouman, K., et al. Identification of a nonsense mutation at the 5' end of the TSC2 gene in a family with a presumptive diagnosis of tuberous sclerosis complex. J Med Genet, 1996, 33(1), p. 47–51.
29. Yinon, Y., Chitayat, D., Blaser, S., et al. Fetal cardiac tumors: a single-center experience of 40 cases. Prenat Diagn, 2010, 30(10), p. 941–949.
30. Zhang, YX., Meng, H., Zhong, DR., et al. Cardiac rhabdomyoma and renal cyst in a fetus: early onset of tuberous sclerosis with renal cystic disease. J Ultrasound Med, 2008, 27(6), p. 979–982.
Labels
Paediatric gynaecology Gynaecology and obstetrics Reproduction medicineArticle was published in
Czech Gynaecology
2016 Issue 2
Most read in this issue
- Current status and recommendations for intrapartum monitoring of fetal heart rate
- Induction of labor
- Posterm pregnancy
- Delivery of macrosomic fetus